These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18947869)
21. Transformation of myelodysplastic syndromes into acute myeloid leukemias. Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365 [TBL] [Abstract][Full Text] [Related]
22. [Study on the transformation from myelodysplastic syndromes into acute leukemias]. Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096 [TBL] [Abstract][Full Text] [Related]
23. Auer rods and myeloperoxidase: an approach for investigating changes at the molecular level in acute myeloid leukaemia (AML). Pearson EC Med Hypotheses; 1989 Nov; 30(3):175-7. PubMed ID: 2557530 [TBL] [Abstract][Full Text] [Related]
24. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436 [TBL] [Abstract][Full Text] [Related]
26. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). Ogasawara T; Yasuyama M; Kawauchi K Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101 [TBL] [Abstract][Full Text] [Related]
27. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. Ghaddar HM; Stass SA; Pierce S; Estey EH Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the distribution and clonal expansion features of the T-cell γδ repertoire in myelodysplastic syndrome-RAEB and RAEB with progression to AML. Geng S; Weng J; Du X; Lai P; Huang X; Chen S; Yang L; Li Y DNA Cell Biol; 2012 Oct; 31(10):1563-70. PubMed ID: 22873198 [TBL] [Abstract][Full Text] [Related]
34. [The man behind the rod: John Auer. A broad-minded physiologist]. Billström R; Stolt CM Lakartidningen; 1995 Sep; 92(39):3577-9. PubMed ID: 7564597 [No Abstract] [Full Text] [Related]
35. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323 [TBL] [Abstract][Full Text] [Related]
36. Auer rod-like inclusions in multiple myeloma. Metzgeroth G; Back W; Maywald O; Schatz M; Willer A; Hehlmann R; Hastka J Ann Hematol; 2003 Jan; 82(1):57-60. PubMed ID: 12574968 [TBL] [Abstract][Full Text] [Related]
37. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801 [TBL] [Abstract][Full Text] [Related]
38. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB). Omine M; Yamauchi H Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556 [TBL] [Abstract][Full Text] [Related]
40. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia]. Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]